HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues

Prediction of hepatocellular carcinoma prognosis based on expression of an immune-related gene set

(2020) Yuting He et al.   Aging-US

NCAPG Is a Promising Therapeutic Target Across Different Tumor Types

(2020) Cuicui Xiao et al.   Frontiers in Pharmacology

Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma

(2020) Santosh K. Singh et al.   Cancers

Upregulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer

(2020) Song Yang et al.   BIOSCIENCE REPORTS

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients

(2020) Baohui Zhang et al.   Journal of Translational Medicine

EFTUD2 maintains the survival of tumor cells and promotes hepatocellular carcinoma progression via the activation of STAT3

(2020) Mengxian Tu et al.   Cell Death & Disease

Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma

(2020) Bo Hu et al.   Cancer Medicine

A global view of hepatocellular carcinoma: trends, risk, prevention and management

(2019) Ju Dong Yang et al.   Nature Reviews Gastroenterology & Hepatology

Multi-omics Analysis of Microenvironment Characteristics and Immune Escape Mechanisms of Hepatocellular Carcinoma

(2019) Wenli Li et al.   Frontiers in Oncology

Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer

(2019) Elin Ersvær et al.   MODERN PATHOLOGY

The clinical value of Fibulin-1 for prognosis and its prospective mechanism in intrahepatic cholangiocarcinoma

(2018) Yusheng Jie et al.   HPB

Metabolic network-based stratification of hepatocellular carcinoma reveals three distinct tumor subtypes

(2018) Gholamreza Bidkhori et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification

(2017) Julien Calderaro et al.   JOURNAL OF HEPATOLOGY

Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma

(2017) Oleg V. Grinchuk et al.   Molecular Oncology

MELK is an oncogenic kinase essential for early hepatocellular carcinoma recurrence

(2016) Hongping Xia et al.   CANCER LETTERS

Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

(2016) Pushkar Malakar et al.   CANCER RESEARCH

Differences in Surgical Outcomes Between Hepatitis B- and Hepatitis C–Related Hepatocellular Carcinoma

(2014) Bernardo Franssen et al.   ANNALS OF SURGERY

GSVA: gene set variation analysis for microarray and RNA-Seq data

(2013) Sonja Hänzelmann et al.   BMC BIOINFORMATICS

Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient Survival

(2011) Stephanie Roessler et al.   GASTROENTEROLOGY

Paradoxical Roles of IL-4 in Tumor Immunity

(2010) Zhiguang Li et al.   Cellular & Molecular Immunology

Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects

(2010) Alejandro Forner et al.   SEMINARS IN LIVER DISEASE

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

(2008) Yujin Hoshida et al.   NEW ENGLAND JOURNAL OF MEDICINE